Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Affirm Stock Is a Wait and See Until August 9’s Quarterly Results

By Chris Lau, InvestorPlace Contributor

AFRM stock will build on its business momentum from here after the company posted strong transaction volumes and merchandise volume growth.

7 Tech Stocks to Buy on Any Dips

By Chris Lau, InvestorPlace Contributor

Tech stocks to buy with temporary stock price dip create great buying opportunities for the long-term investors willing to hold for years.

Should Investors Buy SoFi After its Q1 Earnings Report?

By Chris Lau, InvestorPlace Contributor

Sofi reported strong member growth and product sales in its earnings report. Data that supports its business momentum is still solid.

FuboTV Stock Cratered, But It Is Still a Buy

By Chris Lau, InvestorPlace Contributor

Short-sellers have a concentrated bet against FuboTV even though the stock already lost most of its value from its 52-week high.

AMC Stock: Why it’s Time to Bail Right Now

By Chris Lau, InvestorPlace Contributor

AMC stock relied almost entirely on memes or momentum trading, and once gone, fundamentals will determine its share price.

Load More